NEW YORK, June 7, 2023 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Fulcrum Therapeutics, Inc.. Shareholders who purchased shares of FULC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required…Read More
The Gross Law Firm Notifies Shareholders of Fulcrum Therapeutics Inc of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 27 2023 NASDAQ FULC MarketScreener
